Tag: COVID-19
Bharat Biotech gets DCGI nod for Phase 3 clinical trials of...
The trials for 0.5 ml single dose of nasal vaccine will be conducted at nine locations in the country.
Researchers develop COVID-19 diagnosis technique using X-ray images
Researchers from the Indian Institutes of Technology (IIT) Jodhpur have developed an automated Artificial intelligence (AI) solution for COVID-19 screening
IIT Mandi researchers discover Phytochemicals that inhibit the COVID-19 virus
Researchers from the Indian Institute of Technology Mandi and The International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, have identified Phytochemicals in the petals of a Himalayan plant that could potentially be used to treat COVID-19 infections
80-90% of patients with Covid likely to have underlying heart damage:...
Heart & Lungs are affected in COVID recovered patients as part of post COVID syndrome as 15-30% of patients are affected by it
19th edition of BioAsia to kick-start on 24th February
Over 30,000 participants from more than 70 countries to virtually attend Asia’s largest Biotechnology and Life-sciences forum. Eminent speakers from Government, Industry, Investors and Academia to participate in BioAsia 2022 event
#Budget2022: Tech driven-innovative healthcare solutions must get tax benefits, says Dr...
Union Budget 2022-23 has to be a forward looking budget as we are battling with a two year old plus pandemic affecting lives and livelihoods, says Dr Alok Roy, Chair, FICCI Health Services Committee and Chairman, Medica Group of Hospitals
HCAH raises INR 112 crore to build largest out-of-hospital care platform...
The Investment will help bolster the out-of-hospital care segment in the country - a critical need in view of shortage of hospitals to deliver the best possible health outcomes and quality of life for patients while increasing the access and affordability
Delta & Omicron may both co-circulate: Experts
While Delta has two mutations on the receptor-binding domain of the spike protein, Omicron has 15. This has resulted in evasion from antibody binding, necessary for protection.
Odisha orders 5 lakh Omicron test kits from TATA MD, first...
As OmiSure specifically identifies Omicron without the need for sequencing, it will help the government to combat the Omicron spread within the state.
COVAXIN booster dose study shows promising results
The phase 2, double-blind, randomised controlled COVAXIN trial demonstrated long-term safety with no serious adverse events